✦ LIBER ✦

Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies

✍ Scribed by Nicola P. Klein; Paula Ray; Diane Carpenter; John Hansen; Edwin Lewis; Bruce Fireman; Steven Black; Claudia Galindo; Johannes Schmidt; Roger Baxter

Book ID: 116962199
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 158 KB
Volume: 28
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2009.10.115

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An assessment of the safety of adolescen

An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink

✍ W. Katherine Yih; James D. Nordin; Martin Kulldorff; Edwin Lewis; Tracy A. Lieu; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 295 KB

The use, safety, and effectiveness of he

The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study

✍ Jie Zhang, Elizabeth Delzell, Fenglong Xie, John W Baddley… 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 176 KB

Using time-to-onset for detecting safety

Using time-to-onset for detecting safety signals in spontaneous reports of adverse events following immunization: a proof of concept study

✍ Lionel Van Holle; Ziad Zeinoun; Vincent Bauchau; Thomas Verstraeten 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Data Mining for Prospective Early Detect

Data Mining for Prospective Early Detection of Safety Signals in the Vaccine Adverse Event Reporting System (VAERS): A Case Study of Febrile Seizures after a 2010–2011 Seasonal Influenza Virus Vaccine

✍ David Martin, David Menschik, Marthe Bryant-Genevier, Robert Ball 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 361 KB

(761): A randomized, double-blind, place

(761): A randomized, double-blind, placebo-controlled, multicenter phase IIb study to evaluate the efficacy and safety of multiple alvimopan dosage regimens for the treatment of gastrointestinal adverse events (GIAEs) associated with opioid use in subjects

✍ L. Webster; J. Jansen; J. Peppin; B. Lasko; J. Snidow; A. Pierce; E. Mortensen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 46 KB